Assessing the risk stratification of breast cancer polygenic risk scores in a Brazilian cohort.

Admixed Breast cancer Latinx Polygenic risk score Risk stratification

Journal

The Journal of molecular diagnostics : JMD
ISSN: 1943-7811
Titre abrégé: J Mol Diagn
Pays: United States
ID NLM: 100893612

Informations de publication

Date de publication:
05 Jul 2024
Historique:
received: 09 10 2023
revised: 10 05 2024
accepted: 11 06 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 7 7 2024
Statut: aheadofprint

Résumé

Polygenic risk scores (PRS) for breast cancer (BC) have a clear clinical utility in risk prediction. PRS transferability across populations and ancestry groups is hampered by population-specific factors, ultimately leading to differences in variant effects, such as linkage disequilibrium (LD) and differences in variant frequency (AF-diff). Thus, locally-sourced population-based phenotypic and genomic datasets are essential to assess the validity of PRS derived from signals detected across populations. Here, we assess the transferability of a BC PRS composed of 313 risk variants (313-PRS) in a Brazilian tri-hybrid admixed ancestries (European, African and Native American) whole-genome sequenced cohort, GRAR. We computed 313-PRS in GRAR (n=853) using the UK Biobank (UKBB, n=264,307) as reference. We show that although the Brazilian cohorts have a high European (EA) component, with AF-diff and to a lesser extent LD patterns similar to those found in EA populations, the 313-PRS distribution is inflated when compared to that of the UKBB, leading to potential overestimation of PRS-based risk if EA is taken as a standard. Interestingly, we find that case-controls lead to equivalent predictive power when compared to UKBB-EA samples with AUROC values of 0.66-0.62 compared to 0.63 for UKBB.

Identifiants

pubmed: 38972593
pii: S1525-1578(24)00150-8
doi: 10.1016/j.jmoldx.2024.06.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Rodrigo Araujo Sequeira Barreiro (RAS)

Universidade de São Paulo, Departamento de Bioquímica, São Paulo, SP, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Tatiana Ferreira de Almeida (TF)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. Electronic address: tatiana.almeida@einstein.br.

Catarina Dos Santos Gomes (CDS)

Institute of Psychiatry, University of Sao Paulo, Medical School, São Paulo, SP, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Frederico Monfardini (F)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Allysson Allan de Farias (AA)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Gabriela Chiuffa Tunes (GC)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Gabriel Mesquita de Souza (GM)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Etienne Duim (E)

Big Data and Analytics Department, Hospital Israelita Albert Einstein. São Paulo, SP, Brazil.

Jaqueline de Sá Correia (J)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Antonio Victor Campos Coelho (AV)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Marcel Pinheiro Caraciolo (MP)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Yeda Aparecida Oliveira Duarte (YAO)

Medical-Surgical Nursing Department, School of Nursing, University of São Paulo, São Paulo, SP, Brazil; Epidemiology Department, Public Health School, University of São Paulo, São Paulo, SP, Brazil.

Mayana Zatz (M)

Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, SP, Brazil; Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo, São Paulo, SP, Brazil.

Edson Amaro (E)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

João Bosco Oliveira (JB)

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Bárbara Domingues Bitarello (BD)

Biology Department, Bryn Mawr College. Pennsylvania, EUA.

Helena Brentani (H)

Institute of Psychiatry, University of Sao Paulo, Medical School, São Paulo, SP, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Michel Satya Naslavsky (MS)

Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, SP, Brazil; Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo, São Paulo, SP, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Classifications MeSH